Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ellis

Showing results (1031-1040 of 1,150) with videos related to

Pageof 115
Sort By:
Circulation|January 28, 2012
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacementSachin S Goel, Shikhar Agarwal, E Murat Tuzcu, et al.
The Journal of Physiology|March 27, 2021
Carbohydrate improves exercise capacity but does not affect subcellular lipid droplet morphology, AMPK and p53 signalling in human skeletal muscleJ Marc Fell, Mark A Hearris, Daniel G Ellis, et al.
ACS Photonics|August 26, 2024
Microlens Hollow-Core Fiber Probes for Operando Raman SpectroscopyMegan J Groom, Ermanno Miele, Jonathan Pinnell, et al.
Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.
Journal of the American College of Cardiology|April 4, 2006
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trialGiora Weisz, Martin B Leon, David R Holmes, et al.
The New England Journal of Medicine|July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting InvestigatorsA M Lincoff, R M Califf, D J Moliterno, et al.
Chemical Communications (Cambridge, England)|April 8, 2004
A novel methodology for the synthesis of complexes containing long carbon chains linking metal centres: molecular structures of [Ru(dppe)Cp*]2(mu-C14) and [Co3(mu-dppm)(CO)7]2(mu3:mu3-C16)Alla B Antonova, Michael I Bruce, Benjamin G Ellis, et al.
Journal of the American College of Cardiology|May 14, 2013
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reportingBhuvnesh Aggarwal, Stephen G Ellis, A Michael Lincoff, et al.
JAMA|March 20, 2008
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular riskTamali Bhattacharyya, Stephen J Nicholls, Eric J Topol, et al.
Circulation. Arrhythmia and Electrophysiology|January 1, 2013
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillatorEdwin T Zishiri, Sarah Williams, Edmond M Cronin, et al.
Pageof 115

Showing results (1031-1040 of 1,150) with videos related to

Sort By:
Pageof 115
Circulation|January 28, 2012
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacementSachin S Goel, Shikhar Agarwal, E Murat Tuzcu, et al.
The Journal of Physiology|March 27, 2021
Carbohydrate improves exercise capacity but does not affect subcellular lipid droplet morphology, AMPK and p53 signalling in human skeletal muscleJ Marc Fell, Mark A Hearris, Daniel G Ellis, et al.
ACS Photonics|August 26, 2024
Microlens Hollow-Core Fiber Probes for Operando Raman SpectroscopyMegan J Groom, Ermanno Miele, Jonathan Pinnell, et al.
Biochemical Pharmacology|March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseA G Ellis, M M Doherty, F Walker, et al.
Journal of the American College of Cardiology|April 4, 2006
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trialGiora Weisz, Martin B Leon, David R Holmes, et al.
The New England Journal of Medicine|July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting InvestigatorsA M Lincoff, R M Califf, D J Moliterno, et al.
Chemical Communications (Cambridge, England)|April 8, 2004
A novel methodology for the synthesis of complexes containing long carbon chains linking metal centres: molecular structures of [Ru(dppe)Cp*]2(mu-C14) and [Co3(mu-dppm)(CO)7]2(mu3:mu3-C16)Alla B Antonova, Michael I Bruce, Benjamin G Ellis, et al.
Journal of the American College of Cardiology|May 14, 2013
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reportingBhuvnesh Aggarwal, Stephen G Ellis, A Michael Lincoff, et al.
JAMA|March 20, 2008
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular riskTamali Bhattacharyya, Stephen J Nicholls, Eric J Topol, et al.
Circulation. Arrhythmia and Electrophysiology|January 1, 2013
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillatorEdwin T Zishiri, Sarah Williams, Edmond M Cronin, et al.
Pageof 115